Pallidal versus subthalamic deep-brain stimulation for Parkinson's disease.

By K. Follett, F. Weaver, M. Stern, K. Hur, C. Harris, Ping Luo, W. Marks, Johannes C Rothlind, O. Sagher, C. Moy and 16 more. New England Journal of Medicine, 2010

1,276 citations recorded by the source corpus.

Subfields: Neurology

View Paper: https://www.semanticscholar.org/paper/c287abdeecc6a22074df3a40a508a4f3e0fcd00b

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Neurology

1. Nir Lipsman
2. Andres M. Lozano
3. Michael D. Geschwind
4. Michael G. Erkkinen
5. Mee‐Ohk Kim

Citations in the corpus

• International Parkinson and movement disorder society evidence‐based medicine review: Update on treatments for the motor symptoms of Parkinson's disease (2018, background): “and a 3-year extension of a study by Follett et al.(138,139) One new study evaluated STN DBS for early PD with motor fluctuations (average disease duration 7.”
• Probing and regulating dysfunctional circuits using deep brain stimulation. (2013, positive): “DBS of the subthalamic nucleus or globus pallidus (GPi) for the management of PD was approved in 2002 (Limousin et al., 1998; Follett et al., 2010).”
• Clinical Neurology and Epidemiology of the Major Neurodegenerative Diseases. (2018, background): “Electrodes placed in the globus pallidus internus or subthalamic nucleus regulate abnormal neural impulses, thereby relieving motor symptoms (Benabid et al. 1987; Siegfried and Lippitz 1994; Follett et al. 2010; Odekerken et al. 2016).”